Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year.

NCT02593071 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1330

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus (RSV)

Interventions

BIOLOGICAL: RSV-F Vaccine
BIOLOGICAL: Phosphate Buffer Placebo

Sponsor

Novavax